Cleared Traditional

K881341 - NOVA LITE(TM) SA

K881341 is an FDA 510(k) clearance for NOVA LITE(TM) SA, manufactured by Inova Diagnostics, Inc.. The device is a Class 2 Immunology device with product code LLL cleared through the Traditional 510(k) pathway after a 177-day FDA review.

K881341 · Inova Diagnostics, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1988
Decision
177d
Days
Class 2
Risk

K881341 is an FDA 510(k) clearance for the NOVA LITE(TM) SA. Classified as Extractable Antinuclear Antibody, Antigen And Control (product code LLL), Class II - Special Controls.

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on September 22, 1988 after a review of 177 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Inova Diagnostics, Inc. devices

FDA 510(k) Submission Details - K881341

510(k) Number K881341 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 29, 1988
Decision Date September 22, 1988
Days to Decision 177 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d slower than avg
Panel avg: 105d · This submission: 177d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLL Device Classification - Class 2, Special Controls

Product Code LLL Extractable Antinuclear Antibody, Antigen And Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LLL Extractable Antinuclear Antibody, Antigen And Control

All 146
Devices cleared under the same product code (LLL) and FDA review panel - the closest regulatory comparables to K881341.
NOVA GEL(TM) T JO-1
K896462 · Inova Diagnostics, Inc. · Nov 1989
ANTI-SS-A (RO) AND ANTI-SS-B (LA) ANTIBODY TEST
K895339 · Immco Diagnostics, Inc. · Oct 1989
NOVA GEL(TM) JO-1
K892897 · Inova Diagnostics, Inc. · May 1989
NOVA LITE(TM) AUTOANTIBODY CONTROLS
K881340 · Inova Diagnostics, Inc. · Jun 1988
NOVA GEL (TM) SCL-70
K880897 · Inova Diagnostics, Inc. · Apr 1988
NOVA LITE(TM) ANA PLUS
K881339 · Inova Diagnostics, Inc. · Apr 1988